Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Authors
Keywords
-
Journal
Scandinavian Journal of Urology
Volume 54, Issue 2, Pages 115-121
Publisher
Informa UK Limited
Online
2020-04-08
DOI
10.1080/21681805.2020.1739139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry
- (2016) Jean-Pierre Droz et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Predictors of Time to Metastasis in Castration-resistant Prostate Cancer
- (2016) Daniel M. Moreira et al. UROLOGY
- Evaluation of data quality in the National Prostate Cancer Register of Sweden
- (2015) Katarina Tomic et al. EUROPEAN JOURNAL OF CANCER
- Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
- (2015) Charles J Ryan et al. LANCET ONCOLOGY
- Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden
- (2014) J. Banefelt et al. Cancer Epidemiology
- Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)
- (2014) Dana E. Rathkopf et al. EUROPEAN UROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical predictors of survival in men with castration-resistant prostate cancer
- (2013) Mari Nakabayashi et al. CANCER
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systems Pathology Approach for the Prediction of Prostate Cancer Progression After Radical Prostatectomy
- (2008) Michael J. Donovan et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now